Terms: = Ovarian cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300
58 results:
1. Nanoparticle Targeting in Chemo-Resistant ovarian cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance.
Wang Y; Calvert AE; Cardenas H; Rink JS; Nahotko D; Qiang W; Ndukwe CE; Chen F; Keathley R; Zhang Y; Cheng JX; Thaxton CS; Matei D
Adv Sci (Weinh); 2024 Apr; 11(13):e2305212. PubMed ID: 38263873
[TBL] [Abstract] [Full Text] [Related]
2. Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes.
Møller NB; Boonen DS; Feldner ES; Hao Q; Larsen M; Lænkholm AV; Borg Å; Kvist A; Törngren T; Jensen UB; Boonen SE; Thomassen M; Terkelsen T
Sci Rep; 2023 May; 13(1):8536. PubMed ID: 37237042
[TBL] [Abstract] [Full Text] [Related]
3. Genomic and expressional dynamics of ovarian cancer cell lines in PARPi treatment revealed mechanisms of acquired resistance.
Cheng A; Rao Q; Liu Y; Huang C; Li J; Huo C; Lin Z; Lu H
Gynecol Oncol; 2022 Dec; 167(3):502-512. PubMed ID: 36270832
[TBL] [Abstract] [Full Text] [Related]
4. Network Pharmacology, Molecular Docking, and Experimental Validation to Unveil the Molecular Targets and Mechanisms of Compound Fuling Granule to Treat ovarian cancer.
Li Z; Liu Q; Zhu Y; Wu L; Liu W; Li J; Zhang Z; Tao F
Oxid Med Cell Longev; 2022; 2022():2896049. PubMed ID: 36062197
[TBL] [Abstract] [Full Text] [Related]
5. The Identification by Exome Sequencing of Candidate Genes in
BenAyed-Guerfali D; Kifagi C; BenKridis-Rejeb W; Ammous-Boukhris N; Ayedi W; Khanfir A; Daoud J; Mokdad-Gargouri R
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893033
[TBL] [Abstract] [Full Text] [Related]
6. Oncohistone Mutations Occur at Functional Sites of Regulatory ADP-Ribosylation.
Huang D; Camacho CV; Martire S; Nagari A; Setlem R; Gong X; Edwards AD; Chiu SP; Banaszynski LA; Kraus WL
Cancer Res; 2022 Jul; 82(13):2361-2377. PubMed ID: 35472077
[TBL] [Abstract] [Full Text] [Related]
7. Building the What Comes Next Cohort for
Dossa F; Metcalfe K; Sutradhar R; Little T; Eisen A; Chun K; Meschino WS; Velsher L; Ellis JL; Baxter NN
CMAJ Open; 2021; 9(3):E874-E885. PubMed ID: 34870614
[TBL] [Abstract] [Full Text] [Related]
8. ZCL-082, a boron-containing compound, induces apoptosis of non-Hodgkin's lymphoma via targeting p90 ribosomal S6 kinase 1/NF-κB signaling pathway.
Ma C; Liu M; Zhang J; Cai H; Wu Y; Zhang Y; Ji Y; Shan H; Zou Z; Yang L; Liu L; Xu H; Lei H; Liu C; Zhou L; Cao Y; Zhou H; Wu Y
Chem Biol Interact; 2022 Jan; 351():109770. PubMed ID: 34861246
[TBL] [Abstract] [Full Text] [Related]
9. Design, synthesis and biological evaluation of a novel spiro oxazolidinedione as potent p300/CBP HAT inhibitor for the treatment of ovarian cancer.
Ding H; Pei Y; Li Y; Xu W; Mei L; Hou Z; Guang Y; Cao L; Li P; Cao H; Bian J; Chen K; Luo C; Zhou B; Zhang T; Li Z; Yang Y
Bioorg Med Chem; 2021 Dec; 52():116512. PubMed ID: 34801827
[TBL] [Abstract] [Full Text] [Related]
10.
Gospodinova ZI; Zupkó I; Bózsity N; Manova VI; Georgieva MS; Todinova SJ; Taneva SG; Ocsovszki I; Krasteva ME
Z Naturforsch C J Biosci; 2021 Mar; 76(3-4):129-140. PubMed ID: 32975208
[TBL] [Abstract] [Full Text] [Related]
11. Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
Riedlova P; Janoutova J; Hermanova B
Mol Biol Rep; 2020 Apr; 47(4):2763-2769. PubMed ID: 32180084
[TBL] [Abstract] [Full Text] [Related]
12. Multiparametric MRI Evaluation of Complex ovarian Masses.
Singla V; Dawadi K; Singh T; Prabhakar N; Srinivasan R; Suri V; Khandelwal N
Curr Probl Diagn Radiol; 2021; 50(1):34-40. PubMed ID: 31399230
[TBL] [Abstract] [Full Text] [Related]
13. Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.
Lawrenson K; Song F; Hazelett DJ; Kar SP; Tyrer J; Phelan CM; Corona RI; Rodríguez-Malavé NI; Seo JH; Adler E; Coetzee SG; Segato F; Fonseca MAS; Amos CI; Carney ME; Chenevix-Trench G; Choi J; Doherty JA; Jia W; Jin GJ; Kim BG; Le ND; Lee J; Li L; Lim BK; Adenan NA; Mizuno M; Park B; Pearce CL; Shan K; Shi Y; Shu XO; Sieh W; ; Thompson PJ; Wilkens LR; Wei Q; Woo YL; Yan L; Karlan BY; Freedman ML; Noushmehr H; Goode EL; Berchuck A; Sellers TA; Teo SH; Zheng W; Matsuo K; Park S; Chen K; Pharoah PDP; Gayther SA; Goodman MT
Gynecol Oncol; 2019 May; 153(2):343-355. PubMed ID: 30898391
[TBL] [Abstract] [Full Text] [Related]
14. Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma.
Cuevas D; Valls J; Gatius S; Roman-Canal B; Estaran E; Dorca E; Santacana M; Vaquero M; Eritja N; Velasco A; Matias-Guiu X
Virchows Arch; 2019 May; 474(5):585-598. PubMed ID: 30710169
[TBL] [Abstract] [Full Text] [Related]
15. Combined Targeted Resequencing of Cytosine DNA Methylation and Mutations of DNA Repair Genes with Potential Use for Poly(ADP-Ribose) Polymerase 1 Inhibitor Sensitivity Testing.
Grimm C; Fischer A; Farrelly AM; Kalachand R; Castiglione R; Wasserburger E; Hussong M; Schultheis AM; Altmüller J; Thiele H; Reinhardt HC; Hauschulz K; Hennessy BT; Herwig R; Lienhard M; Buettner R; Schweiger MR
J Mol Diagn; 2019 Mar; 21(2):198-213. PubMed ID: 30576872
[TBL] [Abstract] [Full Text] [Related]
16. SND1 acts upstream of SLUG to regulate the epithelial-mesenchymal transition (EMT) in SKOV3 cells.
Xin L; Zhao R; Lei J; Song J; Yu L; Gao R; Ha C; Ren Y; Liu X; Liu Y; Yao Z; Yang J
FASEB J; 2019 Mar; 33(3):3795-3806. PubMed ID: 30509125
[TBL] [Abstract] [Full Text] [Related]
17. Androgen receptor transcriptional activity and chromatin modifications on the ABCB1/MDR gene are critical for taxol resistance in ovarian cancer cells.
Sun NK; Kohli A; Huang SL; Chang TC; Chao CC
J Cell Physiol; 2019 Jun; 234(6):8760-8775. PubMed ID: 30317630
[TBL] [Abstract] [Full Text] [Related]
18. The proto-oncogene Bcl3 induces immune checkpoint PD-L1 expression, mediating proliferation of ovarian cancer cells.
Zou Y; Uddin MM; Padmanabhan S; Zhu Y; Bu P; Vancura A; Vancurova I
J Biol Chem; 2018 Oct; 293(40):15483-15496. PubMed ID: 30135206
[TBL] [Abstract] [Full Text] [Related]
19. MIR-92 stimulates VEGF by inhibiting von Hippel-Lindau gene product in epithelial ovarian cancer.
Guo FJ; Shao YP; Wang YP; Jin YM; Liu SS; Wang QY
J Biol Regul Homeost Agents; 2017 Jul-Sep,; 31(3):615-624. PubMed ID: 28952293
[TBL] [Abstract] [Full Text] [Related]
20. Multiomics Analysis of Tumor Microenvironment Reveals Gata2 and miRNA-124-3p as Potential Novel Biomarkers in ovarian cancer.
Gov E; Kori M; Arga KY
OMICS; 2017 Oct; 21(10):603-615. PubMed ID: 28937943
[TBL] [Abstract] [Full Text] [Related]
[Next]
